Back
Amicus Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45
FOLD
Amicus Therapeutics
Last Price:
$6.30
Seasonality Move:
3.26%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FOLD is experiencing buying pressure, which is a positive indicator for future bullish movement.
Amicus Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.16 | Sell |
| 20-day SMA: | 5.94 | Buy |
| 50-day SMA: | 6.08 | Sell |
| 200-day SMA: | 8.62 | Sell |
| 8-day EMA: | 5.07 | Buy |
| 20-day EMA: | 3.1 | Buy |
| 50-day EMA: | 1.51 | Buy |
| 200-day EMA: | 0.42 | Buy |
Amicus Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.67 | Buy |
| Relative Strength Index (14 RSI): | 49.98 | Sell |
| Chaikin Money Flow: | 2428427 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.75 - 6.19) | Buy |
| Bollinger Bands (100): | (5.84 - 8.34) | Sell |
Amicus Therapeutics Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amicus Therapeutics Stock
Is Amicus Therapeutics Stock a Buy?
-
Amicus Therapeutics share price is 6.07 while FOLD 8-day simple moving average is 6.16, which is a Sell signal.
-
The stock price of FOLD is 6.07 while Amicus Therapeutics 20-day SMA is 5.94, which makes it a Buy.
-
Amicus Therapeutics 50-day simple moving average is 6.08 while FOLD share price is 6.07, making it a Sell technically.
-
FOLD stock price is 6.07 and Amicus Therapeutics 200-day simple moving average is 8.62, creating a Sell signal.
FOLD Technical Analysis vs Fundamental Analysis
Sell
45
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy or a Sell?
-
Amicus Therapeutics stock is rated a SellThe current Amicus Therapeutics [FOLD] share price is $6.07. The Score for FOLD is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Amicus Therapeutics Stock Info
Market Cap:
1.9B
Price in USD:
6.07
Share Volume:
3.3M
Amicus Therapeutics 52-Week Range
52-Week High:
12.65
52-Week Low:
5.51
Sell
45
Amicus Therapeutics (FOLD)
is a Sell
Amicus Therapeutics Share Price Forecast
-
What is the Amicus Therapeutics stock price today?The Amicus Therapeutics stock price is 6.07 USD today.
-
Will FOLD stock go up or go down?Amicus Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Amicus Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amicus Therapeutics is overvalued.
Is Amicus Therapeutics Stock a Buy?
-
Amicus Therapeutics share price is 6.07 while FOLD 8-day exponential moving average is 5.07, which is a Buy signal.
-
The stock price of FOLD is 6.07 while Amicus Therapeutics 20-day EMA is 3.10, which makes it a Buy.
-
Amicus Therapeutics 50-day exponential moving average is 1.51 while FOLD share price is 6.07, making it a Buy technically.
-
FOLD stock price is 6.07 and Amicus Therapeutics 200-day simple moving average is 0.42, creating a Buy signal.
Fundamental Analysis of Amicus Therapeutics
Is Amicus Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.03 per share, an increase this year of $0.12 per share, and an increase next year of $0.34 per share.
Technical Analysis of Amicus Therapeutics
Should I short Amicus Therapeutics stock?
-
FOLD Moving Average Covergence Divergence (MACD) indicator is 1.67, suggesting Amicus Therapeutics is a Buy
-
Amicus Therapeutics Relative Strength Index (RSI) is 49.98, which suggest Amicus Therapeutics is oversold
-
The Bollinger Bands (25) for Amicus Therapeutics is (5.75 - 6.19), which suggest Amicus Therapeutics is a Sell
-
The Bollinger Bands (100) for Amicus Therapeutics is (5.84 - 8.34), which suggest Amicus Therapeutics is a Sell
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.